The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older
In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicity objectives
These results add to the growing body of evidence indicating a single dose of ABRYSVO provides strong immune protection against outcomes caused by RSV
Strong topline growth driven by solid performance across key brands.
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
_256_384.jpg)
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
Subscribe To Our Newsletter & Stay Updated
